Target
CD8+ T-cells
4 abstracts
Abstract
Study of the Bria-IMT regimen and CPI vs physicians' choice in advanced metastatic breast cancer (BRIA-ABC).Org: University of Washington School of Medicine and Fred Hutchinson Cancer Center, Mayo Clinic Florida, University of Pittsburgh, Hoag Cancer Center, Newport Beach, CA, Morehouse School of Medicine,
Abstract
Correlation of single-cell cytokine secretion with clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with capecitabine (C), bevacizumab (B), ± atezolizumab (A).Org: Duke University Medical Center, Mayo Clinic, Alliance Statistics and Data Management Center, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute,
Abstract
Find: Immunomodulation after a fasting mimicking diet analyzed by Nanostring and multispectral flowcytometry in healthy volunteers: A pilot study.Org: Leiden University Medical Center, Leiden University, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Oncode Institute,
Abstract
Influence of CD47 on CD8+ T-cell and tumor prognosis based on pan-cancer analysis.Org: Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou University of Chinese Medicine, Southern Medical University,